Navigation Links
Isis Reports Follow-Up Data From ISIS-SMN Rx Phase 1 Study In Children With Spinal Muscular Atrophy
Date:9/19/2013

we are in ongoing discussions with them.  We plan to report data from both of these ongoing studies late this year or early next year.  We also plan to begin our Phase 3 clinical program early next year."                                             

The Phase 1 study was an open-label, single-dose, dose-escalation study designed to assess the safety, tolerability and pharmacokinetic profile of ISIS-SMNRx in medically stable children from age 2-14.  In this study, children with Type II or Type III SMA received ISIS-SMNRx as a single dose of 1, 3, 6, or 9 mg administered intrathecally.  In addition to measurements of drug concentration in plasma and cerebral spinal fluid, exploratory analyses of changes in motor function were conducted.  Gross motor movements were measured using the HFMSE, a modified version of the Hammersmith Functional Motor Scale.  The HFMSE is used to assess responses on 33 motor function tasks, each scored on a scale from 0 to 2 and allows for assessment of any SMA patient aged 2 or older.  HFMSE has demonstrated good test-retest reliability in other studies.

Data from this study was reported at the American Academy of Neurology in March 2013, showing that a single-dose of ISIS-SMNRx was well tolerated in children with SMA at all dose levels tested and that improvements were observed in HFMSE scores in a number of children, with a mean increase in HFSME scores for the 9 mg cohort at three months was 3.1 points.  The data to be reported at the World Muscle Congress in October is a follow on analysis of HFMSE in 24 children who had completed the Phase 1 study.

ABOUT ISIS-SMNRx
ISIS-SMNRx is designed to alter
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
2. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
3. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
4. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
5. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
6. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
7. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
8. Luminex Corporation Reports First Quarter 2012 Results
9. Hospira Reports First-Quarter 2012 Results
10. Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
11. The Female Health Company Reports Second Quarter Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  A novel wearable injector slightly larger than an Oreo cookie ... self-inject prescription drugs in the large doses required to treat ... deficiencies, and genetic disorders.  An emerging biologic ... according to analysts.   Many of these drugs will require a ...
(Date:1/14/2014)... , Jan. 14, 2014 Dynamic Healthcare Services, Inc. ("DHS"), ... that it acquired Progressive Home Medical Equipment, Inc. ("Progressive") of ... The terms of the acquisition were not disclosed. ... company providing a wide range of sleep, mobility, and respiratory ...
(Date:1/14/2014)... N.Y. , Jan. 14, 2014   Oligomerix, Inc. , ... modifying therapeutics for Alzheimer,s disease (AD) and related neurodegenerative ... to Valhalla, NY as of ... laboratory space at New York Medical College. ...
Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
(Date:4/23/2014)... Wash.Researchers at Washington State University Spokane have developed ... about to nod off behind the wheel. , ... wheel movementswhich are more variable in drowsy driversand ... currently available video-based driver drowsiness detection systems. , ... when a car is drifting out of its ...
(Date:4/23/2014)... give exercise enthusiasts the extra nudge they need during ... cyber buddy can help. , The study, which appears ... the first to indicate that although a human partner ... partner also can be effective. , "We wanted to ... people to give greater effort while exercising than if ...
(Date:4/23/2014)... high-energy particles, simulating conditions astronauts would face on a ... slower reaction times, even when the radiation exposure is ... which affected a large subset, but far from ... to protein changes in the brain, the scientists say. ... suggest it may be possible to develop a biological ...
(Date:4/23/2014)... have identified an important enzyme pathway that helps prevent ... chromosomes, a condition that has been directly linked to ... of biochemistry, found that near the end of cell ... ensures any breaks in DNA are fully repaired before ... daughter cells. This process helps safeguard against some of ...
(Date:4/23/2014)... area of the gastro-intestinal tract has long been considered ... at the Sahlgrenska Academy have used refined microscopic techniques ... inner surface of the gastro-intestinal tract is only as ... Fndriks. , The digestive tract, which passes from the ... has a length of about 5 meters in a ...
Breaking Medicine News(10 mins):Health News:WSU innovation improves drowsy driver detection 2Health News:Cyber buddy is better than 'no buddy' 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 3Health News:Study identifies enzymes that help fix cancer-causing DNA defects 2Health News:The surface area of the digestive tract 'only' as large as a studio apartment 2
... cold, according to a Newcastle University led study. Leukaemia and ... a respiratory virus or even a mild flu. //This is ... genetically susceptible to cancer. ,Edinburgh University’s Professor Freda Alexander ... lead to the development of a vaccine which will serve ...
... There is an increase in demand for Palliative care ... Annual Survey of Hospitals, which has been reported in ... to patients where chemotherapy or other treatments no more ... patients to lessen their suffering. It is found that ...
... a non-invasive sensor that will help treat patients ... patient faces respiratory distress in the emergency room ... a mask. But for some people with chronic ... the body's breathing reflex. , ,Spotting at-risk ...
... inquest is being conducted into the death of Rene Anderson ... cannabis-based drug. The Sativex drug is derived from the plant, ... drug was administered to Rene Anderson for relieving her of ... reported to have developed psychosis after the administration of the ...
... African-Americans are generally reluctant to enroll in treatment trials for ... January 15, 2006 issue of CANCER, the journal of the ... the drugs that are a part of the chemotherapy regimen ... than women. Lawmakers as well as researchers have stressed the ...
... researchers of University of North Carolina reveal that women ... //This links an external factor like night shift ... factor can influence premature delivery by 50%. ,The ... pregnant women. Additionally the study found standing for long ...
Cached Medicine News:
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: